Follicular Non-Hodgkin's Lymphoma with Refractory Paraneoplastic Pemphigus: Case Report with Review of Novel Treatment Modalities

References

• Kimyai-Asadi, A. and Ming, H.J. (2001) "Paraneoplastic pemphi-gus", Int. J. Dermatol., 40, 367–372.
   Google Scholar
• Sapadin, A.N. and Anhalt, G.J. (1998) "Paraneoplastic pemphigus with a pemphigus vegetans-like plaque as the only cutaneous manifestation", J. Am. Acad. Dermatol., 39(5 Pt 2), 867–871.
   PubMed Web of Science ®Google Scholar
• Joly, P., Richard, C., Gilbert, D., Courville, P., Chosidow, O., Roujeau, J.C., et al. (2000) "Sensitivity and specificity of clinical, histologic, and immunologic features in the diagnosis of para-neoplastic pemphigus", J. Am. Acad. Dermatol., 43(4), 619–626.
   PubMed Web of Science ®Google Scholar
• Wang, L., Bu, D., Yang, Y., Chen, X. and Zhu, X. (2004) "Castleman's tumours and production of autoantibody in para-neoplastic pemphigus", Lancet, 363(9408), 525–531.
   PubMed Web of Science ®Google Scholar
• Tankel, M., Tannenbaum, S. and Parekh, S. (1993) "Paraneoplastic pemphigus presenting as an unusual bullous eruption", J. Am. Acad. Dermatol., 29(5 Pt 2), 825–828.
   PubMed Web of Science ®Google Scholar
• Toth, G.G. and Jonkman, M.F. (2001) "Therapy of pemphigus", Clin. Dermatol., 19(6), 761–767.
   Web of Science ®Google Scholar
• Nousari, H.C. and Anhalt, G.J. (1999) "Pemphigus and bullous pemphigoid", Lancet, 354(9179), 667–672.
   PubMed Web of Science ®Google Scholar
• Bystryn, J.C. and Steinman, N.M. (1996) "The adjuvant therapy of pemphigus. An update", Arch. Dermatol., 132(2), 203–212.
   Web of Science ®Google Scholar
• Bystryn, J.C., Jiao, D. and Natow, S. (2002) "Treatment of pemphigus with intravenous immunoglobulin", J. Am. Acad. Dermatol., 47(3), 358–363.
   PubMed Web of Science ®Google Scholar
• Razzaque Ahmed, A. (2001) "Intravenous immunoglobulin therapy in the treatment of patients with pemphigus vulgaris unresponsive to conventional immunosuppressive treatment", J. Am. Acad. Derma-tol., 45(5), 679–690.
   PubMed Web of Science ®Google Scholar
• Mazzi, G., Raineri, A., Zanolli, F.A., Da Ponte, C., De Roia, D., Santarossa, L., et al. (2003) "Plasmapheresis therapy in pemphigus vulgaris and bullous pemphigoid", Transfus Apheresis Sci., 28(1), 13–18.
   PubMed Web of Science ®Google Scholar
• Toth, G.G. and Jonkman, M.F. (1999) "Successful treatment of recalcitrant penicillamine-induced pemphigus foliaceus by low-dose intravenous immunoglobulins", Br. J. Dermatol., 141(3), 583–585.
   Web of Science ®Google Scholar
• Turner, M.S., Sutton, D. and Sauder, D.N. (2000) "The use of plasmapheresis and immunosuppression in the treatment of pemphigus vulgaris", J. Am. Acad. Dermatol., 43(6), 1058–1064.
   PubMed Web of Science ®Google Scholar
• Tan-Lim, R. and Bystryn, J.C. (1990) "Effect of plasmapheresis therapy on circulating levels of pemphigus antibodies", J. Am. Acad. Dermatol., 22(1), 35–40.
   PubMed Web of Science ®Google Scholar
• Toth, G.G., van de Meer, J.B. and Jonkman, M.F. (2002) "Dexamethasone pulse therapy in pemphigus", J. Eur. Acad. Dermatol. Venereol., 16(6), 607–611.
   PubMed Web of Science ®Google Scholar
• Gooptu, C., Littlewood, Ti., Frith, P., Lyon, C.C., Carmichael, A.J., Oliwiecki, S., et al. (2001) "Paraneoplastic pemphigus: an association with fludarabine?", Br. J. Dermatol., 144(6), 1255 — 1261.
   Web of Science ®Google Scholar
• Reich, K., Brinck, U., Letschert, M., Blaschke, V., Dames, K., Braess, J., et al. (1999) "Graft-versus-host disease-like immunophe-notype and apoptotic keratinocyte death in paraneoplastic pemphi-gus", Br. J. Dermatol., 141(4), 739–746.
   Web of Science ®Google Scholar
• Braess, J., Reich, K., Willert, S., Strutz, F., Neumann, C., Hiddemann, W., et al. (1997) "Mucocutaneous autoimmune syndrome following fludarabine therapy for low-grade non-Hodg-kin's lymphoma of B-cell type (B-NHL)", Ann. Hematol., 75(5-6), 227–230.
   Web of Science ®Google Scholar
• Bazarbachi, A., Bachelez, H., Dehen, L., Delmer, A., Zittoun, R. and Dubertret, L. (1995) "Lethal paraneoplastic pemphigus following treatment of chronic lymphocytic leukaemia with fludarabine", Ann. Oncol., 6(7), 730–731.
   Google Scholar
• Lee, M.S., Kossard, S., Ho, K.K., Barnetson, R.S. and Ravich, R.B. (1995) "Paraneoplastic pemphigus triggered by radiotherapy", Australas J. Dermatol., 36(4), 206 — 210.
   Google Scholar
• Fried, R., Lynfield, Y., Vitale, P. and Anhalt, G. (1993) "Paraneoplastic pemphigus appearing as bullous pemphigoid-like eruption after palliative radiation therapy", J. Am. Acad. Dermatol., 29(5 Pt 2), 815–817.
   PubMed Web of Science ®Google Scholar
• Toth, G.G. (2002) Management of pemphigus. Rijksuniversiteit Groningen, Thesis.
   Google Scholar
• Bohn, J., Jonsson, S. and Holst, R. (1999) "Successful treatment of recalcitrant cicatricial pemphigoid with a combination of plasma exchange and cyclophosphamide", Br. J. Dermatol., 141(3), 536 — 540.
   Web of Science ®Google Scholar
• Yano, C., Ishiji, T., Kamide, R. and Niimura, M. (2000) "A case of pemphigus vulgaris successfully treated with single filtration plasmapheresis: a correlation of clinical disease activity with serum antibody levels", J. Dermatol., 27(6), 380— 385.
   PubMedGoogle Scholar
• Razzaque Ahmed, A., Avram, M.M. and Duncan, L.M. (2003) "Case 23-2003: a 79-year-old woman with gastric lymphoma and erosive mucosal and cutaneous lesions", N. Eng. J. Med., 349(4), 382— 391.
   Google Scholar
• Hainsworth, JD., Burris, HA., III, Morrissey, L.H., Litchy, S., Scullin, D.C., Jr., Bearden, J.D., III, et al. (2000) "Rituximab monoclonal antibody as initial systemic therapy for patients with low-grade non-Hodgkin lymphoma", Blood, 95(10), 3052 — 3056.
   PubMed Web of Science ®Google Scholar
• Heizmann, M., Itin, P., Wernli, M., Borradori, L. and Bargetzi, M.J. (2001) "Successful treatment of paraneoplastic pemphigus in follicular NHL with rituximab: report of a case and review of treatment for paraneoplastic pemphigus in NHL and CLL", Am. J. Hematol., 66(2), 142–144.
   PubMed Web of Science ®Google Scholar
• Borradori, L., Lombardi, T., Samson, J., Girardet, C., Saurat, J.H. and Hugli, A. (2001) "Anti-CD20 monoclonal antibody (rituximab) for refractory erosive stomatitis secondary to CD20( +) follicular lymphoma-associated paraneoplastic pemphigus", Arch. DermatoL, 137(3), 269 — 272.
   Web of Science ®Google Scholar
• Salopek, T.G., Logsetty, S. and Tredget, E.E. (2002) "Anti-CD20 chimeric monoclonal antibody (rituximab) for the treatment of recalcitrant, life-threatening pemphigus vulgaris with implications in the pathogenesis of the disorder", J. Am. Acad. Dermatol., 47(5), 785 — 788.
   PubMed Web of Science ®Google Scholar
• Schadlow, M.B., Anhalt, G.J. and Sinha, A.A. (2003) "Using rituximab (anti-CD20 antibody) in a patient with paraneoplastic pemphigus", J. Drugs DermatoL, 2(5), 564 — 567.
   PubMedGoogle Scholar
• Slifka, M.K., Antia, R., Whitmire, J.K. and Ahmed, R. (1998) "Humoral immunity due to long-lived plasma cells", Immunity, 8(3), 363–372.
   PubMed Web of Science ®Google Scholar
• Cooper, H.L., Healy, E., Theaker, J.M. and Friedmann, P.S. (2003) "Treatment of resistant pemphigus vulgaris with an anti-CD20 monoclonal antibody (Rituximab)", Clin. Exp. DermatoL, 28(4), 366–368.
   Web of Science ®Google Scholar
• Oostingh, G.J., Sitaru, C., Kromminga, A., Dormann, D. and Zillikens, D. (2002) "Autoreactive T cell responses in pemphigus and pemphigoid", Autoimmun. Rev., 1(5), 267–272.
   Google Scholar